Brayton Purcell LLP

Call For A Free Consultation
800-598-0314

Call For A Free Consultation 800-598-0314

Brayton Purcell LLP
  • Home
  • Firm Overview
    • Our Beliefs
      • Giving Back
      • Our Associations And Memberships
      • The Right To Trial By Jury
    • Regions Served
    • Careers
    • Our Employees Pets
    • Press Releases
  • Attorneys
  • Practice Areas
    • Mesothelioma/Asbestos
    • Personal Injury/Wrongful Death
    • Toxic Substances
    • Estate Planning
    • Other Areas Of Practice
  • Court Successes
    • Trial Verdicts
    • Appeals
  • Testimonials
  • Blog
  • Contact
  • Home
  • Firm Overview
    • Our Beliefs
      • Giving Back
      • Our Associations And Memberships
      • The Right To Trial By Jury
    • Regions Served
    • Careers
    • Our Employees Pets
    • Press Releases
  • Attorneys
  • Practice Areas
    • Mesothelioma/Asbestos
    • Personal Injury/Wrongful Death
    • Toxic Substances
    • Estate Planning
    • Other Areas Of Practice
  • Court Successes
    • Trial Verdicts
    • Appeals
  • Testimonials
  • Blog
  • Contact

New research suggests mesothelioma cells may be killed quicker

On behalf of Brayton Purcell LLP | Jul 24, 2014 | Asbestos-Related Illness

We frequently write about the challenges that mesothelioma patients face. This condition can be painful, debilitating and even fatal. Thankfully, certain treatments can improve the prognosis of certain patients diagnosed with mesothelioma. For example, some patients benefit from drug therapies, others from surgery, others from chemotherapy and others may benefit from a combination of these treatments.

Recently, international researchers determined that combining a certain compound with a specific immunosuppressant may help to make chemotherapy more successful for mesothelioma patients in particular. Their conclusions are based on lab tests and have yet to be confirmed in human patients. However, the research is promising and is therefore worth noting.

Specifically, Turkish researchers found that when they combine the immunosuppressant RAD001 with the compound EF24, the resulting reaction aids in successfully killing mesothelioma cells. EF24 is a compound which is chemically similar to tumeric’s yellow pigment. For whatever reason, combining this compound with a specific immunosuppressant creates a uniquely destructive reaction in regards to mesothelioma cells while remaining inert in regards to healthy cells.

The study’s lead author explained this reaction another way when he noted recently that, “Our preliminary results suggest that pretreatment with EF24 or RAD001 may reduce the cytotoxic effect of cisplatin on nonmalignant mesothelial cells and increase cell death response of malignant pleural mesothelioma cells.” The researchers even determined that the resulting compound may be less damaging to healthy cells than chemotherapy alone tends to be.

Mesothelioma can be a devastating diagnosis. However, improvements in treatment and the evolution of research focused on this condition may provide reasons for hope in mesothelioma patients.

Source: BusByWay, “New Research Finds Pretreatment of Mesothelioma Cells with These Two Compounds Boosts Chemotherapy Response, According to Surviving Mesothelioma,” July 23, 2014

Recent Posts

  • EPA Risk Evaluation for Chrysotile Asbestos
  • Caring for Someone with Mesothelioma: What to Know
  • 2020 shows promise in the fight for a mesothelioma cure
  • Asbestos in Makeup Products Is a Problem That Is Not Going Away
  • How Did I Get Mesothelioma?

Archives

Categories

RSS Feed

Subscribe To This Blog’s Feed

Free Consultation

Take The First Step In Resolving Your Issue. Send Us An Email.

Email Us For A Response

San Francisco
Bay Area Office

222 Rush Landing Road Novato, CA 94945

Novato Office
222 Rush Landing Road
Novato, CA 94945
Toll Free: 800-598-0314
Phone: 415-898-1555
Fax: 415-898-1247

Map & Directions

Southern California
Office

12 28th Street Venice, California 90291

Los Angeles Office
12 28th Street
Venice, California 90291
Toll Free: 800-598-0314
Phone: 415-898-1555
Fax: 415-898-1247

Map & Directions
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

© 2021 Brayton Purcell LLP. All Rights Reserved.

Disclaimer | Site Map | Privacy Policy | Business Development Solutions by FindLaw, part of Thomson Reuters

Review Us